Investigational Drug Information for Chronocort
✉ Email this page to a colleague
What is the drug development status for Chronocort?
Chronocort is an investigational drug.
There have been 11 clinical trials for Chronocort.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 30th 2022.
The most common disease conditions in clinical trials are Adrenogenital Syndrome, Adrenal Hyperplasia, Congenital, and Hyperplasia. The leading clinical trial sponsors are Diurnal Limited, Simbec Research, and National Institutes of Health (NIH).
There are five hundred and eighty-seven US patents protecting this investigational drug and zero international patents.
Summary for Chronocort
| US Patents | 587 |
| International Patents | 34,006 |
| US Patent Applications | 4,342 |
| WIPO Patent Applications | 2,760 |
| Japanese Patent Applications | 124 |
| Clinical Trial Progress | Phase 3 (2022-03-30) |
| Vendors | 51 |
Recent Clinical Trials for Chronocort
| Title | Sponsor | Phase |
|---|---|---|
| Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia | Diurnal Limited | Phase 3 |
| Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency | Diurnal Limited | Phase 2 |
| Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia | Diurnal Limited | Phase 3 |
Clinical Trial Summary for Chronocort
Top disease conditions for Chronocort
Top clinical trial sponsors for Chronocort
US Patents for Chronocort
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Chronocort | ⤷ Sign Up | Methods and compositions for inhibition of Ras | ARAXES PHARMA LLC (San Diego, CA) | ⤷ Sign Up |
| Chronocort | ⤷ Sign Up | IBAT inhibitors for the treatment of liver diseases | Albireo AB (Gothenburg, SE) | ⤷ Sign Up |
| Chronocort | ⤷ Sign Up | Ammonia oxidizing bacteria for treatment of eczema | AOBIOME LLC (Cambridge, MA) | ⤷ Sign Up |
| Chronocort | ⤷ Sign Up | Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same | STC.UNM (Albuquerque, NM) Sandia Corporation (Albuquerque, NM) | ⤷ Sign Up |
| Chronocort | ⤷ Sign Up | Pyrrolidine amide compounds as histone demethylase inhibitors | GENENTECH, INC. (South San Francisco, CA) CONSTELLATION PHARMACEUTICALS INC. (Cambridge, MA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Chronocort
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Chronocort | World Intellectual Property Organization (WIPO) | WO2015087340 | 1989-12-31 | ⤷ Sign Up |
| Chronocort | European Patent Office | EP3158977 | 2035-10-20 | ⤷ Sign Up |
| Chronocort | Australia | AU2010206683 | 2029-01-23 | ⤷ Sign Up |
| Chronocort | Brazil | BRPI1006942 | 2029-01-23 | ⤷ Sign Up |
| Chronocort | Canada | CA2749217 | 2029-01-23 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
